These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 8251285
1. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Naguib M, Abdulatif M, al-Ghamdi A, Hamo I, Nouheid R. Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285 [Abstract] [Full Text] [Related]
2. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Naguib M, Abdulatif M, al-Ghamdi A. Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753 [Abstract] [Full Text] [Related]
5. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4. Kopman AF, Mallhi MU, Justo MD, Rodricks P, Neuman GG. Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908 [Abstract] [Full Text] [Related]
6. Neostigmine but not edrophonium prolongs the action of mivacurium. Symington MJ, Mirakhur RK, Kumar N. Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970 [Abstract] [Full Text] [Related]
16. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium. Devcic A, Munshi CA, Gandhi SK, Kampine JP. Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038 [Abstract] [Full Text] [Related]
17. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Smith CE, Donati F, Bevan DR. Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767 [Abstract] [Full Text] [Related]